pd 142505-0028 has been researched along with quinazolines in 1 studies
| Studies (pd 142505-0028) | Trials (pd 142505-0028) | Recent Studies (post-2010) (pd 142505-0028) | Studies (quinazolines) | Trials (quinazolines) | Recent Studies (post-2010) (quinazolines) |
|---|---|---|---|---|---|
| 11 | 1 | 0 | 19,235 | 2,417 | 8,835 |
| Protein | Taxonomy | pd 142505-0028 (IC50) | quinazolines (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.027 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleu, J; Marsal, J; Ros, E; Solsona, C | 1 |
1 other study(ies) available for pd 142505-0028 and quinazolines
| Article | Year |
|---|---|
Effects of CI-1002 and CI-1017 on spontaneous synaptic activity and on the nicotinic acetylcholine receptor of Torpedo electric organ.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cholinesterase Inhibitors; Electric Organ; Electrophysiology; In Vitro Techniques; Muscarinic Agonists; Muscarinic Antagonists; Neuromuscular Junction; Nicotinic Antagonists; Oocytes; Oximes; Quinazolines; Receptors, Nicotinic; Synapses; Torpedo; Xenopus laevis | 2000 |